Company press releases and official corporate announcements.
A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.
23,794 total articles
Liquidia Corporation announced that its COO/CFO and Chief Business Officer will provide a business update during a fireside chat at the Wells Fargo 21st Annual Healthcare Conference. The presentation will include insights on their proprietary PRINT technology, current marketed products, and investigational therapies for respiratory and vascular dis…
Conexeu Sciences Inc., a preclinical-stage biotechnology company focused on regenerative tissue restoration, will participate in several investor and industry conferences in September and October 2026. The company plans to engage stakeholders while advancing its CXU™ extracellular matrix platform, targeting multiple large markets including wound ca…
Spectral AI, a Nasdaq-listed US medical AI company, will present at the H.C. Wainwright 28th Annual Global Investment Conference to highlight its recent FDA De Novo clearance for its DeepView System targeting burn wound diagnostics. The company emphasizes advancements in leadership, partnerships, and financial positioning, aiming to commence commer…
Autonomix Medical, Inc. announced that two scientific abstracts demonstrating the potential of its transvascular technology for pain management and nervous system mapping have been accepted for poster presentation at the CIRSE 2026 Annual Congress. The presentations focus on the use of their catheter-based microchip sensing array technology to addr…
Alpha Compute Corp., a Nasdaq-listed AI infrastructure company, announced its sponsorship of the 9/11 & Freedom 250 Gala in New York City, commemorating the 25th anniversary of the September 11 terrorist attacks and the USA's 250th anniversary. The gala supports organizations benefiting veterans, community, and education. CEO Brittany Kaiser will a…
Gaming and Leisure Properties, Inc. declared a third quarter 2026 cash dividend of $0.82 per share, up from $0.78 in the same quarter last year, representing a 7.8% annualized yield based on the recent share price. The dividend will be paid on September 25, 2026. The company, a REIT specializing in gaming property leases, signaled its intention to …
Biomerica, Inc. reported its fiscal year 2026 financial results, showing a 17% increase in Q4 net sales, a 24% improvement in full-year net loss, and key commercial advancements including Medicare reimbursement for its inFoods IBS test. The company completed a $2.23 million financing to support ongoing commercialization and strategic initiatives.
Navitas Semiconductor announces the first shipments of its 5th Generation GaNFast™ GaN power semiconductors manufactured domestically at GlobalFoundries' U.S.-based 200mm GaN-on-Si facility. This collaboration strengthens U.S. semiconductor supply chains for critical AI infrastructure, high-performance computing, industrial electrification, and nat…
VivoSim Labs announces development of a rat liver model to complement its existing human liver NAMkind™ platform, aiming to improve drug toxicity testing by differentiating species-specific toxicological effects. This bi-species comparative model is designed to help pharmaceutical companies better assess drug safety and reduce premature termination…
Wetour Robotics Limited has demonstrated its Orchestra system, integrating surface electromyography (sEMG) wristband data with first-person vision to overcome limitations of vision-only robot training. The fusion of muscle activation data with visual input enables more accurate capture of hand movement and force, even during occlusions, improving d…
22nd Century Group, a Nasdaq-listed leader in low-nicotine tobacco products, reports accelerating growth with expanded retail presence from 2,000 to an expected 5,000 outlets by year-end 2026, improved gross margins driven by branded products, and consistent monthly sales growth. The company remains focused on commercial execution and innovation, l…
ProMIS Neurosciences Inc., a clinical-stage biotech developing antibody therapeutics for neurodegenerative diseases, announced participation in several key investor and healthcare conferences throughout September 2026. The company will present updates on its EpiSelect™ platform and lead candidate PMN310, currently in an ongoing Phase 1b trial for e…
Daxor Corporation, a Nasdaq-listed medical diagnostics company specializing in precise blood volume measurement technology, delivered a mid-year corporate update highlighting its financial strength, commercial expansion with new sales leadership, manufacturing capacity investments, and ongoing clinical validation supporting its innovative next-gene…
CDT Equity Inc. appointed co-founder James Bligh as CEO to lead its next growth phase following several strategic developments including balance sheet strengthening and a key investment in quantum signature intelligence company Sarborg. Bligh’s background in public markets and finance is expected to guide CDT's focus on science-driven asset develop…
Rezolve Ai PLC reported an extraordinary 1,970% revenue increase to $130.8 million in H1 2026, driven by expanded customer base and robust partner-led distribution with Microsoft, Google, TCS, and Tech Mahindra. The company’s proprietary AI commerce infrastructure technology received critical validation through Google's infrastructure-level deploym…
Nurix Therapeutics, a clinical-stage biopharmaceutical company focusing on targeted protein degradation therapies, announced that its management will participate in several upcoming investor conferences in September 2026, including those hosted by Wells Fargo, C. Wainwright, Baird, and Morgan Stanley. These events will feature fireside chats that w…
Voyager Therapeutics, a biotechnology company focused on genetic treatments for neurological disorders, announced participation in several upcoming investor conferences including Wells Fargo, Cantor, Morgan Stanley, Baird, and H.C. Wainwright. The company will hold multiple fireside chats to discuss its pipeline and partnerships, with a webcast ava…
Legend Biotech announced that interim CEO Alan Bash will participate in a fireside chat at the Morgan Stanley Global Healthcare Conference on September 15, 2026. The event aims to provide insights into the company's advancements in cell therapy, particularly regarding their CAR-T treatment for multiple myeloma, CARVYKTI.
Intuitive Machines announced a new contract to build two IM 300 series spacecraft platforms for an undisclosed new customer. The IM 300 is a versatile and modular satellite platform designed for multiple mission types and payloads, produced at their high-volume Palo Alto facility. This order indicates growing demand across commercial, civil, and na…
Enphase Energy announced that over 7,500 U.S. homeowners have enrolled in its Enphase Care premium support program for solar and battery systems. This service provides proactive monitoring, warranty support, and no-cost repair visits, enhancing customer confidence and extending the company's long-term relationship with clients. Enphase expects to e…
Vor Bio, a clinical-stage biotechnology company focused on treating autoimmune diseases, has announced its management team's participation in several major healthcare and biopharma investor conferences throughout September 2026. These include presentations and meetings at events hosted by Wells Fargo, Citi, Morgan Stanley, Baird, and Stifel, with l…
Cabaletta Bio, a late-stage clinical biotechnology company focused on autoimmune disease therapies, will participate in several investor conferences in September 2026, including Wells Fargo, Cantor Global Healthcare, Morgan Stanley, and H.C. Wainwright events, featuring meetings and webcasted fireside chats to update stakeholders about their clinic…
Fervo Energy has entered a 396 MW power purchase agreement with Google for carbon-free energy from its Cape Station enhanced geothermal systems GeoCluster expected online in 2028. The agreement includes an option for Google to expand purchases to nearly 1 GW by 2030 to support a potential data center in Utah. This deal marks a significant step in d…
Akebia Therapeutics announced that its CEO and CFO will participate in one-on-one meetings at the Wells Fargo Healthcare Conference in Boston, where they will discuss the company's commercial products and clinical-stage kidney disease pipeline.
Scribe Therapeutics, a Nasdaq-listed clinical-stage biotech company specializing in in vivo CRISPR therapies, announced management's participation in several investor conferences in September and October 2026. The company focuses on developing genetic medicines aimed at preventing and treating cardiometabolic diseases, with its lead candidate STX-1…
